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Available online 19 April 2019Long-term intelligence andmemory outcomes of children post convulsive status epilepticus (CSE) have not been
systematically investigated despite evidence of short-term impairments in CSE. The present study aimed to de-
scribe intelligence andmemory outcomes in childrenwithin 10 years of CSE and identify potential risk factors for
adverse outcomes. In this cohort study, children originally identiﬁedby the population-basedNorth London Con-
vulsive Status Epilepticus in Childhood Surveillance Study (NLSTEPSS) were prospectively recruited between
July 2009 and February 2013 and invited for neuropsychological assessments and magnetic resonance imaging
(MRI) scans. Full-scale intelligence quotients (FSIQs) were measured using the Wechsler Abbreviated Scales of
Intelligence (WASI), and global memory scores (GMS) was assessed using the Children's Memory Scale (CMS).
The cohort was analyzed as a whole and stratiﬁed into a prolonged febrile seizures (PFS) and non-PFS group.
Their performancewas comparedwith population norms and controls. Regressionmodelswere ﬁtted to identify
predictors of outcomes. With a mean of 8.9 years post-CSE, 28.5% of eligible participants were unable to under-
take testing because of their severe neurodevelopmental deﬁcits. Childrenwith CSE who undertook formal test-
ing (N= 94) were shown to have signiﬁcantly lower FSIQ (p= 0.001) and GMS (p= 0.025) from controls; the
PFS group (N= 34) had lower FSIQs (p= 0.022) but similar memory quotients (p= 0.88) with controls. Intra-
cranial volume (ICV), developmental delay at baseline, and active epilepsy at follow-up were predictive of long-
term outcomes in the non-PFS group. The relationship between ICV and outcomes was absent in the PFS group
despite its presence in the control and non-PFS groups. Post-CSE, survivors reveal signiﬁcant intelligence and
memory impairments, but prognosis differs by CSE type; memory scores are uncompromised in the PFS group
despite evidence of their lower FSIQwhereas both are compromised in the non-PFS group. Correlations between
brain volumes and outcomes differ in the PFS, non-PFS, and control groups and require further investigation., convulsive sta
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. This is an open© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
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Convulsive status epilepticus (CSE) is the most common neurologi-
cal emergency in childhood [1] and is associated with a greater risk of
pediatric mortality [2], structural brain abnormalities [3–14], and an
overall poorer quality of life [15]. It is becoming increasingly evident
that children with CSE, even those with no apparent neurological prob-
lemsprior to CSE, showevidence of short-term structural and functionaltus epilepticus;
eillance Study;
cranial volume.
y, UCL Institute
access article undercomplications after CSE [4,5,8–11,14]. Long-term outcomes after CSE in
childhood are unclear; most studies that have been conducted to inves-
tigate this issue are either hospital-based, conducted retrospectively,
and/or have involved both adults and children [16–18]. Only one pro-
spective population-based study has focused on long-term outcomes
of CSE in childhood, which, nevertheless, utilizes broad measures and
does not investigate memory outcomes [19].
Our group carried out a 10-year follow-up study (the Status Epilepticus
in Childhood Outcomes Study (STEPSOUT)) that was speciﬁcally designed
to determine the prevalence, spectrum, clinical, and sociodemographic
predictors of neurobehavioral outcomes of childhood CSE utilizing stan-
dardized assessments [20]. The inception cohort consisted of children
identiﬁed and studied in the ﬁrst-ever population-based study focused
on the epidemiology of childhood CSE, i.e., the North London Convulsive
Status Epilepticus in Childhood Surveillance Study (NLSTEPSS) [21].the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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logical problems, epilepsy, and behavioral issues in children who had
CSE compared with the general population, with children who had
prolonged febrile seizures (PFS) having a better prognosis than children
whose initial episode of CSE was non-PFS [21,22]. In the present paper,
we report our ﬁndings on intelligence andmemory outcomes aswell as
the factors associated with lower intelligence and memory abilities
within 10 years of CSE. We present our results stratiﬁed according to
All CSE, PFS, and non-PFS cases. Given our previous research where
we studied children within a year of CSE [4,5,8,9], we hypothesized
that within 10 years post-CSE, (a) children with all forms of CSE
would show deﬁcits relative to controls and population norms and
(b) children with non-PFS would be more affected than those who
had PFS.
2. Methods
2.1. Participants and procedures
In this prospective cohort study, we targeted recruitment of all sur-
viving children originally identiﬁed during the NLSTEPSS [21] (detailed
recruitment methods described elsewhere) [20]. Children were classi-
ﬁed into All CSE, and subsequently stratiﬁed according to etiology into
PFS and non-PFS. Prolonged febrile seizurewas deﬁned as a seizure last-
ing longer than 30min and occurring between the ages of 6months and
5 years in the presence of fever and not caused by an acute or a remote
insult to the central nervous system.
For the recruitment of healthy controls, we sent all-user emails to
employees of Great Ormond Street Hospital (GOSH), a specialist tertiary
care hospital based in London, and Young Epilepsy (YE), a national epi-
lepsy charity. Parents volunteered participation of their children. Exclu-
sion criteria for healthy control participation were a diagnosis of
seizures/epilepsy and/or the presence of neurodevelopmental delay,
as reported by their parents. We obtained written informed consent
from all participants' parents/guardians, andwhere appropriate, we ob-
tained assent from participants themselves. To examine the inﬂuence of
socioeconomic status (SES) on outcomes, indices of multiple depriva-
tion (IMDs) based on residential postal codes were determined for all
participants (http://www.ons.gov.uk) as a measure of their SES.
2.2. Assessments
All participants were invited for a magnetic resonance imaging
(MRI) and neuropsychological assessments at UCL Great Ormond Street
Institute of Child Health (ICH) in London. The Wechsler Abbreviated
Scales of Intelligence (WASI) [23] was used to obtain a full-scale intelli-
gence quotient (FSIQ), a verbal intelligence quotient (VIQ), and a perfor-
mance intelligence quotient (PIQ). The Children's Memory Scale (CMS)
[24]wasused to obtain a globalmemory scores (GMS). Both tests have a
normative mean of 100 and a standard deviation of 15.
Brain MRIs were carried out on an Avanto 1.5 Tesla scanner (Sie-
mens, Erlangen, Germany) using conventional brain MRI sequences.
This was done for the following: (a) to assess the presence of structural
brain abnormalities in this cohort and (b) to extract hippocampal and
intracranial volume (ICV) measurements to investigate their relation-
ship with memory and cognitive indices. Images were reviewed by an
experienced pediatric neuroradiologist who determined whether
scans were (1) normal, (2) contained a minor abnormality (abnormal
feature thought to be either unrelated to this CSE episode/no functional
signiﬁcance), or (3) contained a major abnormality (abnormal feature
likely to have signiﬁcant impact on the child/represent a cause for this
CSE episode) [25]. Two of the authors (SP and MM), blind to all clinical
details, carried out the manual tracing of each hippocampus on 3D fast
low angle shot (FLASH) images. Their measurements were averaged
to arrive at a mean hippocampal value (HV). Intracranial volume wascalculated using the brain extraction tool in FSL (https://fsl.fmrib.ox.
ac.uk/fsl/fslwiki).
2.3. Statistical analysis
Analyses were conducted with Predictive Analytics Software
(PASW) version 21 (Chicago, IL, U.S.A.) forWindows. Independent sam-
ple t-tests and chi-squared tests were used for intergroup comparisons.
Univariate analysis of variance (ANOVA) controlling for age and SESwas
used to compare PFS, non-PFS, and control groups on FSIQ score and
GMS; analysis was restricted to FSIQ rather than its constituents VIQ
and PIQ as we did not observe any discrepancies between VIQ and PIQ
in our sample. One sample t-tests were conducted to compare CSE
group means with the population norms. Signiﬁcant difference in test
results was set at p b 0.05.
To identify factors associated with lower intelligence and memory
scores according to etiological classiﬁcation, we performed separate re-
gression analyses for all patients with CSE, PFS, and non-PFS. To assess
whether any CSE features were directly related to outcome, we investi-
gated the following in the regression analyses: (a) duration of CSE
(min), (b) CSE type (intermittent versus continuous), and (c) CSE loci
(focal versus generalized). In addition, given past literature in this
ﬁeld, we also investigated whether (d) age at CSE, (e) recurrence of
CSE, (f) active epilepsy at follow-up, (g) cognitive delay at baseline
(yes/no), (h) motor delay at baseline (yes/no), (i) previous seizures at
baseline (febrile, afebrile/epilepsy, no seizures), (j) MRI visible struc-
tural abnormalities at follow-up (no/minor abnormalities/major abnor-
malities), and (k) prematurity (yes/no) affected outcomes. Antiepileptic
drugs were not entered as an independent variable as they are highly
correlated with active epilepsy at follow-up. Finally, given the well-
established role of the hippocampus in cognition, we also included
(l) mean HV (mm3) in our regression analyses as well as (m) ICV
(mm3), which served as a proxy for total brain volume. Bootstrapping
of 1000 samples was applied to all our analyses. Any factors signiﬁcant
on univariable analyses at the p b 0.1 level were subsequently included
in multivariable modeling (stepwise regression) to identify the factors
associated with neurocognitive outcomes after adjustment of others.
Finally, given the nature of the study population,we anticipated that
some participants would be unable to participate in our neuropsycho-
logical assessment because of their severe developmental delay. Such
data would not have beenmissing at random. The overhaulingmajority
of participants who were not assessable on the WASI and the CMS had
non-PFS (bar one child with PFS). To address this matter, we imputed
the minimum value (FSIQ = 50) for each participant with non-PFS
that was not assessable on the WASI; a similar strategy has been used
in other studies of children with seizures [26]. Imputed FSIQ scores
were only applied in the regression analysis to compare with ﬁndings
from the completed-case approach.
3. Results
3.1. Participant characteristics
We identiﬁed 183 (90%) of the 203 survivors from the inception CSE
cohort for participation in the current study; 20 subjectswere lost to fol-
low-up. One hundred and thirty-two children (65% of inception cohort
survivors) participated in the study (i.e., agreed to take part in neuro-
psychological assessments and provided clinical data), forty-nine re-
fused study participation altogether, and two provided follow-up data
but refused neuropsychological and MRI scanning (51 refusals in
total) (see Fig. 1 for ﬂow chart of study recruitment). From the 132 par-
ticipants, a bigger proportion was preterm and had generalized-onset
CSE compared with the 71 nonparticipants (51 refusals and 20 lost to
follow-up). The two groupswere similar in all other CSE-related, clinical
and demographic variables (Supplemental Table 1).
Fig. 1. Flow chart of recruitment and assessments. WASI =Wechsler Abbreviated Scales of Intelligence, FSIQ = full-scale intelligence quotient, CMS= Children's Memory Scale, GMS=
global memory score, PFS = prolonged febrile seizure, and non-PFS = nonprolonged febrile seizure.
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assessed with the WASI, a mean of 8.6 years following CSE to derive a
FSIQ. From the remaining participants, 38 (1 PFS, 37 non-PFS) were not
assessed with our neuropsychological instruments, due to their severe de-
velopmental delay (2 out of these 38 children had an MRI). Children with
PFS who undertook neuropsychological testing (N = 34) were similar to
the nonparticipating PFS survivors (N = 22) for all variables except for a
larger representation of females in study participants (χ2 (1) = 5.04, p =
0.03). In thenon-PFS groupof childrenwhocompleted the FSIQassessment
(N = 60), there was a signiﬁcantly smaller proportion of children with
cognitive delay (χ2 (1) = 15.31, p b 0.001) and motor delay at baseline
(χ2 (1) = 7.57, p = 0.007) than children who did not participate (N =
87). Moreover, children with non-PFS classiﬁed as having any type of
seizures (i.e., febrile or afebrile) prior to CSE baselinewere less likely to par-
ticipate in our neuropsychological assessments (χ2 (1)= 12.4, p= 0.002).
Seventy-seven children (34 PFS, 43 non-PFS) out of 94 childrenwho
were assessed on the WASI were also tested on the CMS. Seventeen
non-PFS cases could not be assessed on the CMS because of their severe
learning difﬁculties (mean FSIQ difference between participants able to
complete CMS (mean: 94.6) and those unable (mean: 60.2): t (92) =
−9.4, p b 0.001).
Seventeen neurologically healthy control subjects without a history
of febrile or afebrile seizures (see Table 1 for group characteristics) pro-
vided CMS and WASI data for comparison.3.2. Neuropsychological results
3.2.1. All CSE group comparisons
With a mean of 8.6 years post-CSE, children had signiﬁcantly lower
FSIQ (t = 4.24, p = 0.001; d = 1.23) and GMS (t = 1.92, p = 0.025;
d = 0.54) scores than controls (see Table 2).3.2.2. Group comparisons stratiﬁed by PFS and non-PFS
Mean FSIQ was lowest in children who had non-PFS, higher in chil-
dren who had PFS, and highest in controls (see Table 2). Univariate
ANOVA comparing the PFS, the non-PFS, and the control groups on
FSIQ scores with age and SES as covariates revealed an effect of group
(F = 17.13, p b 0.001, η2 = 0.24; power = 1). Post-hoc comparisons
with Bonferroni corrections revealed that the PFS group had lower
FSIQ scores compared with controls (p= 0.022) but higher FSIQ scores
compared with the non-PFS group (p = 0.001). In turn, the non-PFS
group, had lower FSIQ scores than the control group (p = 0.001).
The mean GMS was also lowest in the non-PFS group, higher in the
PFS group, and highest in controls (Table 2) with univariate ANOVA
with age and SES as covariates conﬁrming an effect of group (F =
6.75, p = 0.002, η2 = 0.13; power = 0.91). The PFS group's mean
GMS was not signiﬁcantly different to controls (p = 0.9), but GMS
were higher in the PFS group compared with the non-PFS group (p =
Table 1
Demographic and clinical characteristics of study participantswhowere able to complete a FSIQ assessment (n=94) comparedwith all (n= 109) other survivors of the inception cohort
who did not have FSIQ assessment (n = 109: 20 lost to follow-up, 51 study refusals, and 38 untestable), and controls (n = 17).
Study participants who completed FSIQ
assessment (N = 94)
Survivors of inception cohort
without FSIQ assessment
(N = 109)
Controls (N = 17)
PFS (N = 34) Non-PFS (N = 60) PFS (N = 22) Non-PFS (N = 87) (N = 17)
Gender (female:male) 18:16 27:33 5:17 51:36 10:7
Age at CSE in months (SD) 19.38 (14.08) 50.36 (37.35) 23.41 (12.07) 62.46 (50.55) –
Age at follow-up in years (SD) 10.04 (1.51)⁎ 12.89 (3.39)⁎ – – 12.37 (3.10)⁎
IMD at CSE (SD) 33.52 (16.99) 32.72 (14.40) 31.88 (12.56) 35.3 (13.66) 24.16 (17.71)
Full-term (N36 weeks) (%) 30 (88.2%) 48 (80%) 19/20 (95%) 66/77 (85.7%) 54/59 (78.3%)
Diagnosis of epilepsy (before or during
follow-up) (%)
5 (14.7%) 39 (65%) – – –
Seizures prior to CSE (%) 11 (32.4%) 33 (55.5%) 8 (36.4%) 64/86 (74.4%) –
Motor delays at CSE baseline (%) 0 12 (20%) 0 34/81 (42%) –
Cognitive delays at CSE baseline (%) 0 29/59 (49.2%) 0 52/73 (71.2%) –
CSE duration in minutes (SD) 83.5 (89.26) 88.7 (73.75) 80.91 (50.06) 92.79 (111.70) –
Focal CSE (%) 6 (17.6%) 28 (46.7%) 7 (31.8%) 38 (43.7%) –
Continuous CSE (%) 18 (52.9%) 29(48.3%) 12 (54.5%) 40 (46%) –
CSE recurrence (%) 10 (29.4%) 27 (45%) – –
Normal MRI at follow-up (%) 29 (85.3%) 28/54 (46.7%) – – 17 (100%)
Mean HV measured at follow-up (SD) 3210.35 mm3 (361.6)⁎ 2949.54 mm3 (425.8)⁎ – – 3124.96 mm3 (248.12)⁎
ICV measured at follow-up (SD) 1,470,954.6 mm3 (150,687.5) 1,453,130.74 mm3 (228,040.9) – – 1,479,983.82 mm3 (121,489.440)
Abbreviations: prolonged febrile seizures (PFS), convulsive status epilepticus (CSE), index of multiple deprivation (IMD), intracranial volume (ICV), hippocampal volume (HV), magnetic
resonance imaging (MRI), standard deviation (SD), and North London Convulsive Status Epilepticus in Childhood Surveillance Study (NLSTEPSS).
⁎ Signiﬁcant results at the p b 0.05 level after Bonferroni correction for ANOVA comparisons between the PFS participants, non-PFS participants, and controls.
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0.002).
3.2.3. Comparison with test derived means
The All CSE group obtained lower scores than the normativemean for
FSIQ (t =−5.25, p= 0.001; d=−0.54, power: 0.99), VIQ (t=−5.10,
p b 0.001; d =−0.53), and PIQ (t =−4.8, p b 0.001; d =−0.50) but
did not differ from the test-provided GMSmeans (t=−1.44, p=0.15;
d=−0.16). The PFS group obtained FSIQ (d= 0.03), VIQ (d= 0.008),
and PIQ (d= 0.05) scores that were not signiﬁcantly different from the
normative mean (p N 0.05), nor was there any difference in GMS with
the normative mean (t = 1.9, p = 0.07; d = 0.33, power: 0.48). The
non-PFS group performed signiﬁcantly worse than the normative
mean for FSIQ (t =−6.48, p b 0.001; d =−0.84, power: 1), PIQ (t =Table 2
Results from the WASI and the CMS for all groups.
All CSE PFS Non-PFS Controls
FSIQ
N 94 34 60 17
Mean 88.4 100.4 81.6 111.5
Standard deviation 21.4 13.8 22 15.8
Range 50–134 74–120 50–134 82–138
VIQ
N 93 34 59 17
Mean 89.03 100.1 82.7 110.5
Standard deviation 20.73 12.04 22.04 15.99
Range 55–131 74–123 55–131 74–129
PIQ
N 92 34 58 17
Mean 89.7 100.8 83.2 109.88
Standard deviation 20.6 15.96 20.3 15.26
Range 53–134 68–131 53–134 88–145
GMS
N 77 34 43 17
Mean 96.4 105.7 89 107.4
Standard deviation 22.2 17.5 22.9 18
Range 50–134 67–133 50–134 68–137
Abbreviations: Wechsler Abbreviated Scales of Intelligence (WASI), full-scale intelligence
quotient (FSIQ), Children'sMemory Scale (CMS), globalmemory scores (GMS), prolonged
febrile seizures (PFS), convulsive status epilepticus (CSE), and number of participants (N).−6.17, p b 0.001; d = −0.78, power: 0.1), and VIQ (t = −5.73, p b
0.001; d = −0.83, power: 0.1) as well as the GMS (t = −3.15, p =
0.003; d =−0.48, power: 0.9).
3.3. Regression results
The results of the univariable regression analyses can be found in
Table 3 and Supplemental Table 2. In the All CSE group analysis, lower
FSIQ scores were independently associated with smaller ICVs at
follow-up (B = 2.78, p = 0.008), cognitive delay at baseline CSE (B =
−13.31, p = 0.02), the occurrence of previous seizures at CSE (B =
−5.16, p = 0.05), and the presence of active epilepsy at follow-up
(B = −11.72, p = 0.06) (R2 = 0.51, p b 0.001). Lower GMS were
associated with the occurrence of previous seizures at the time
of CSE (B = −9.21, p = 0.007) and cognitive delay at baseline
CSE (B = −23.66, p = 0.001) (R2 = 0.36, p b 0.001).
For the PFS group, no variable was retained in the multivariable
model. For the non-PFS group, a smaller ICV at follow-up (B =
4.02, p = 0.002), active epilepsy at follow-up (B = −16.96, p =
0.005), and cognitive delay at CSE baseline (B =−3.22, p = 0.011)
were associated with lower FSIQ scores (R2 = 0.57, p b 0.001). The
same result was obtained in our all-inclusive non-PFS regression
analysis (R2 = 0.61, p b 0.001). Lower GMS were associated with
cognitive delay at baseline (B = −29.14, p b 0.001) (R2 = 0.33, p b
0.001).
For the control group, at the multivariable level, ICV was predictive
of FSIQ (R2 = 0.46, p = 0.003).
4. Discussion
This novel prospective study investigated intelligence and mem-
ory outcomes in a population-based cohort within ten years post-
CSE. Children with a history of CSE were shown to have lower FSIQ
scores and GMS than controls as well as population norms. This dif-
ference was primarily driven by children classiﬁed as non-PFS;
those classiﬁed as PFS had lower FSIQs than controls but scored in
the average range on the WASI. Their GMS were on a par with con-
trols and population norms.
Sixty-ﬁve percent of children classiﬁed as non-PFS received a diag-
nosis of epilepsy at the time of their initial CSE or during their follow-
Table 3
Results from the univariable regression for the three participant groups.
PFS Non-PFS Controls
FSIQ
Age at CSE in months B =−0.13, p = 0.46 B =−0.06, p = 0.46 N/A
Prematurity (b36 weeks) B =−2.48, p = 0.74 B =−14.5, p = 0.01⁎ N/A
MRI visible abnormalities B =−9.06, p = 0.22 B =−12.2, p = 0.04⁎ N/A
Seizures prior to CSE B =−9.52, p = 0.07& B =−14.25, p = 0.001⁎ N/A
Active epilepsy N/A B =−26.467, p b 0.001⁎ N/A
Motor delays at CSE N/A B =−29.58, p b 0.001⁎ N/A
Cognitive delays at CSE N/A B =−33, p b 0.001⁎ N/A
Duration of CSE B =−0.02, p = 0.41 B =−0.58, p = 0.06& N/A
Focal CSE B = 1.29, p = 0.81 B =−5.41, p = 0.38 N/A
Continuous CSE B = 4.13, p = 0.37 B =−3.98, p = 0.5 N/A
CSE recurrence B =−4.59, p = 0.41 B =−17.99, p = 0.001⁎ N/A
Mean HV at follow-up B =−0.01, p = 0.13 B = 0.02, p = 0.001⁎ B = 0.01, p = 0.5
ICV B = 9.24, p = 0.64 B = 5.68, p = 0.003⁎ B = 8.8, p = 0.002⁎
GMS
Age at CSE in months B =−0.023, p = 0.93 B =−0.01, p = 0.92 N/A
Prematurity (b36 weeks) B =−5.58, p = 0.59 B =−16.89, p = 0.05⁎ N/A
MRI visible abnormalities B =−15.83, p = 0.03⁎ B =−8.13, p = 0.32 N/A
Seizures prior to CSE B =−12.15, p = 0.08& B =−11.85, p = 0.005⁎ N/A
Active epilepsy N/A B =−20.988, p = 0.065& N/A
Motor delays at CSE N/A B =−28.47, p = 0.003⁎ N/A
Cognitive delays at CSE N/A B =−30.32, p b 0.001⁎ N/A
Duration of CSE B =−0.03, p = 0.42 B =−0.09, p = 0.22 N/A
Focal CSE B = 6.06, p = 0.33 B =−14.61, p = 0.042⁎ N/A
Continuous CSE B = 4.86, p = 0.43 B =−13.74, p = 0.06& N/A
CSE recurrence B =−11.73, p = 0.12 B =−17.97, p = 0.013⁎ N/A
Mean HV at follow-up B =−0.01, p = 0.11 B = 0.02, P = 0.004⁎ B =−0.02, p = 0.42
ICV at follow-up B =−3.10, p = 0.89 B = 4.62, p = 0.066& B = 4.89, p = 0.1
Abbreviations: Prolonged febrile seizures (PFS), convulsive status epilepticus (CSE), socioeconomic status (SES), intracranial volume (ICV), hippocampal volume (HV),magnetic resonance
imaging (MRI), and Not applicable (N/A).
⁎ p b 0.05.
& p b 0.10.
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telligence outcomes. In a recent study, 40% of children with active epi-
lepsy were shown to obtain FSIQs below 70 pointing to the
intellectual vulnerability of this group [27]. In the present study, we
also report a recurring association [5] between the presence of previous
seizures at CSE and a worse long-term outlook in this population. This
result may be explained by the “multiple insult” hypothesis whereby
CSE plus more seizures equals worse outcomes than CSE alone or sei-
zures alone [28]. Alternatively, it can be argued that the occurrence of
previous seizures at CSE indicates a graver underlying pathology and
could serve as a useful biomarker for clinicians for identifying the
most “at-risk of long-term sequelae” cases.
A better long-term neurocognitive outcome in children with non-
PFS was predicted by larger brain volumes, marked in the present
study by ICV measured at follow-up, as well as the absence of cognitive
delay at baseline. The relationship between ICV and intelligence is well
documented in the literature [29,30] and is perhaps not surprising in the
current context. Namely, smaller brain volumes at baseline CSE could be
a marker for worse concomitant neurological problems. Conversely, a
larger brain might be associated with increased plasticity following an
initial insult. This is supported by a recent study in guppies that reports
that a bigger brain size leads to increased levels of neuroplasticity [31].
The ﬁnding that cognitive delay at baseline predicts neurocognitive out-
comes within ten years is consistent with our earlier ﬁndings where
(a) signs of developmental problems prior to CSE were predictive of
outcomes within 6 weeks and (b) cognitive composite and language
scores obtained at 6 weeks were strongly correlated to overall outcome
at one year [9].
The PFS group obtained signiﬁcantly higher FSIQs than the non-
PFS group and signiﬁcantly lower FSIQs than healthy controls
mirroring ours and others' ﬁndings within one year of CSE [9]. The
ﬁnding that FSIQs were similar to population norms in this group
may be a result of the Flynn effect; a tendency of IQ scores to increase
over time and the failure of measuring tools to keep up with thischange [32]. Another potential contributing consideration is that
the WASI, which we used to measure FSIQ in the present study,
tends to overestimate FSIQ compared with theWechsler Intelligence
Scale for Children IV [33]. Thus, the current ﬁndings may reﬂect an
overestimation of this group's abilities in their intellectual functions.
However, the present ﬁndings serve to corroborate previous reports
of the absence of intellectual disabilities in this group. Whether
learning difﬁculties are more prevalent in this population would re-
quire more in depth investigations using instruments such as the
Wechsler Individual Achievement test [34].
Since we have previously shown that incidental recognition
memory was reduced within 6 weeks as well as one year post-PFS
[8], it was unexpected to ﬁnd that the PFS group was no different
to controls or population norms on the CMS in the current study. A
potential explanation for this discrepancy could be that the inciden-
tal recognition memory paradigm adopted for our early outcomes
study recruits different brain structures and mental processes than
the CMS. This has been indicated in several past studies that have
demonstrated dissociations in performance on incidental recogni-
tion and explicit recognition tasks [35-37]. In support of this, our
original one-year outcome data showed no signiﬁcant correlations
between CMS and incidental recognition memory scores in the 8 in-
dividuals where both measures were collected [38]. Moreover, ﬁnd-
ings obtained from our early outcome studies might have picked up
on transient cognitive changes resulting from the CSE incident. To
adjudicate between these two possibilities, we would need to ad-
minister an incidental recognition paradigm to our long-term
follow-up CSE cohort.
Lastly, the absence of a relationship between ICV and outcomes in
the PFS group despite its evidence in the non-PFS and control groups
(see Fig. 2) was unexpected and requires further investigation. A possi-
ble explanation for this is that post-CSE, there is reorganization of corti-
cal matter as well as microstructural reorganization [3,37] that breaks
down the typical brain function relationships in this group.
Fig. 2. Relationship between ICV and FSIQ in the PFS, non-PFS, and control groups. Abbreviations: prolonged febrile seizures (PFS), controls (CTRLS), full-scale intelligence quotient (FSIQ),
and intracranial volume (ICV).
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Onepossible limitation of the current study is attrition,with 34%of the
inception cohort not providing follow-up data. Nevertheless, loss to
follow-up is inevitable in long-term cohort studies, and the 34% dropout
observed in the present study is considered acceptable for such long-
term follow-up studies [39-40]. A comprehensive comparison of partici-
pants and nonparticipants on demographics and clinical characteristics
revealed differences between the two groups solely in the proportion of
children born prematurely and children who had a generalized-onset
CSE versus a focal onset. The twogroupswere similar in all other variables
suggesting that the studied group is a good representation of the entire
cohort.
Secondly, 28.5% of our sample was unable to provide numerical data
because of their inability to complete assessments. Nevertheless, rather
than being a limitation, this attrition reﬂects the outlook of children fol-
lowing CSE associated with neurological complications and speaks to
their pervasive difﬁculties. In addition, this level of attrition did not
take place within the PFS group who, in their overhauling majority,undertook neuropsychological assessments (bar one childwith intellec-
tual disability and autism). Moreover, when we included the whole
non-PFS group by substituting nonscores with the lowest possible
FSIQ score, regression results remained unchanged suggesting that the
predictors identiﬁed in our study are generalizable to the entire studied
population.
Thirdly, it could be argued thatwe recruited amodestly sized control
group that were the offspring of hospital and university employees and,
consequently, may have been an intrinsically higher functioning group.
Nevertheless, the CSE group as a whole was not statistically different in
SES, gender, and age to our group of controls. In addition, we controlled
for age and SES in all our subgroup analyses. On top of that, our overall
ﬁndings remained consistent when comparisons were made with the
instruments' population normative data arguing against this notion.
Using the more recent edition of the WASI (i.e., WASI-II) may have
been preferable as the older version (WASI-I), which was published in
1999, may have overestimated FSIQs in the present study. Nevertheless,
study recruitment was well underway (July 2009–February 2013)
when the WASI-II was released in 2011 [41].
24 M.M. Martinos et al. / Epilepsy & Behavior 95 (2019) 18–25Finally, with recent advances in the identiﬁcation of certain genetic
mutations (e.g., SCN1A), the current classiﬁcation system may be ob-
scuring further divisions within each group driven by their genetic het-
erogeneity. Thus, our ﬁndings should be considered keeping these
limitations in mind.
5. Conclusion
Childrenwithin ten years of CSE reveal intelligence andmemory im-
pairments relative to controls and population norms, albeit these are
strongly associated with the etiology of CSE. Children classiﬁed as
non-PFS at baseline have aworse outcome associatedwith the presence
of cognitive delay pre-CSE and ICV at follow-up. Children with a history
of PFS reveal no memory impairments on the CMS.
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